Sangamo Therapeutics, Inc.
SGMO
|
News
|
$0.4911
-5.72%
-6.07%
1.2M
|
Health Technology
(0.0% 1d) (-19.0% 1m) (-67.7% 1y) (0.0% 2d) (2.0% 3d) (2.0% 7d) (79.78% volume)
Earnings Calendar: 2024-02-21
Market Cap: $ 101,901,094
http://www.sangamo.com
Sec Filling | Patents | 354 employees
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Brisbane, CA.
gene therapies genomic autoimmunity genome editing urea immunology t-cell nervous system metabolic ceiling
add to watch list Paper trade email alert is off
Press-releases
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.4%
H: 2.37%
C: 0.66%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 1.96%
H: 9.62%
C: 0.0%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 5.49%
H: 2.84%
C: -0.65%
trials meeting set therapeutics therapy
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: -4.77%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 3.13%
H: 0.38%
C: -2.68%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: -2.15%
H: 2.58%
C: 0.92%
candidate payment for collaboration program therapeutics milestone
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-26 (Crawled : 20:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: -0.1%
H: 1.0%
C: -4.5%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 0.38%
H: 6.39%
C: 3.14%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.16%
H: 0.25%
C: -2.51%
nasdaq grants therapeutics
Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
Published: 2024-03-22 (Crawled : 13:00) - biospace.com/
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -5.18%
H: 0.54%
C: -23.59%
million direct offering therapeutics
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: -1.65%
H: 4.59%
C: 2.24%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.72%
H: 2.29%
C: 2.21%
ferguson medical therapeutics
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
business year therapeutics financial results
Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
therapeutics
Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 2.2%
H: 5.62%
C: 3.35%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 0.88%
H: 0.88%
C: -1.75%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.05%
H: 1.45%
C: 0.99%
candidate payment collaboration therapeutics therapy milestone
Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast
Published: 2024-02-21 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.0%
H: 0.92%
C: 0.92%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -6.78%
H: 13.64%
C: 12.27%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.14%
H: 0.58%
C: -1.65%
conference therapeutics
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research
Published: 2024-02-20 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 1.72%
H: 1.82%
C: -1.43%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -1.45%
H: 0.74%
C: -13.24%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.63%
H: 0.8%
C: -0.37%
disease alzheimer’s research preclinical tau program therapeutics therapy
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 16000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
WABC | $47.86 0.21% 0.21% 140K
|
Finance
|
19:30
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
TPL P 3 | $589.01 0.2% -0.04% 53K
|
Miscellaneous
|
15:01
ISBA P 966 | $18.0001 1.63% 3.1K
|
Finance and Insurance
|
15:01
MEGI | $12.04 0.5% 0.0% 150K
|
|
00:30
CTRN P 29000 | $22.11 -0.54% -0.54% 65K
|
Retail Trade
|
22:00
CONN | $3.78 2.16% 2.12% 36K
|
Retail Trade
|
21:30
CMTV P 700 | $16.59 17.43% 1K
|
Finance and Insurance
|
18:30
FNB | $13.67 0.29% 0.0% 2.2M
|
Finance
|
17:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10